APA

Beckers E. A., Faas B. H., Ligthart P., Overbeeke M. A., von dem Borne A. E., van der Schoot C. E. & van Rhenen D. J. (19970701). Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. : Transfusion.

Chicago

Beckers E A, Faas B H, Ligthart P, Overbeeke M A, von dem Borne A E, van der Schoot C E and van Rhenen D J. 19970701. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. : Transfusion.

Harvard

Beckers E. A., Faas B. H., Ligthart P., Overbeeke M. A., von dem Borne A. E., van der Schoot C. E. and van Rhenen D. J. (19970701). Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. : Transfusion.

MLA

Beckers E A, Faas B H, Ligthart P, Overbeeke M A, von dem Borne A E, van der Schoot C E and van Rhenen D J. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. : Transfusion. 19970701.